NEW YORK, Sept. 14, 2022 /PRNewswire/ -- The myopia and presbyopia treatment market size is expected to grow by USD 7.22 billion between 2021 and 2026, accelerating at a CAGR of 7.94% during the forecast period. The report identifies AbbVie Inc., Alcon Inc., Bausch Health Co. Inc., BVI Medical Inc., and Carl Zeiss AG as some of the key vendors. With the presence of several global and regional vendors, global myopia and presbyopia market is fragmented. The competition in the market is expected to intensify over the forecast period with the launch of new products by vendors.
Understand the scope of the full report. Download PDF Report Sample
The report segments the market by type (myopia treatment and presbyopia treatment) and geography (Asia, North America, Europe, and the Rest of the World (ROW)).
By type, the market will observe significant growth in the myopia treatment segment over the forecast period. The segment is mainly driven by the rising prevalence of myopia and the availability of advanced products to treat the condition.
By region, Asia will emerge as the major market, occupying 38% of the global market share. The increasing incidence of myopia in countries such as Japan, Singapore, China, and South Korea is driving the growth of the regional market.
The market is driven by the increasing prevalence of myopia and presbyopia. In 2020, 1.1 billion people across the world had distance vision impairment or uncorrected presbyopia. The prevalence of this condition is high in regions such as East Asia, South Asia, and Southeast Asia. In addition, according to the WHO, half of the world population may be myopic by 2050. Thus, with the growing prevalence of myopia and presbyopia, the demand for treatment options such as contact lenses, concave lenses, and corrective lenses is set to increase over the forecast period. This, in turn, will drive the growth of the market in focus.
Vendor Landscape:
Global myopia and presbyopia treatment market is fragmented. The vendors in the market compete in terms of pricing, R&D, quality, geographical coverage, product offerings, and the development of technologically advanced products. The competition in the market will become more intense with the increase in the number of myopia and presbyopia incidences requiring surgical treatments. Besides, key vendors in the market are continuously launching new products to increase their market share in global myopia and presbyopia treatment market. All these factors are expected to intensify the competition in the market during the forecast period.
Technavio considers the following as the dominant players in the market.
- AbbVie Inc.
- Alcon Inc.
- Bausch Health Co. Inc.
- BVI Medical Inc.
- Carl Zeiss AG
- Essilor International SAS
- Haag Streit Group
- Johnson and Johnson
- NIDEK Co. Ltd
- Ophtec BV
- Orasis Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc.
- Sanjeevan School For Perfect Eyesight
- Sydnexis Inc.
- The Cooper Companies Inc.
- Topcon Corp.
- Ziemer Ophthalmic Systems AG
Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request Sample Report Here
Related Reports:
- Ophthalmic Lens Market by Product and Geography - Forecast and Analysis 2021-2025
- Ophthalmic Diagnostic Devices Market by Product and Geographic Landscape - Forecast and Analysis 2022-2026
Myopia and Presbyopia Treatment Market Scope | |
Report Coverage | Details |
Page number | 120 |
Base year | 2021 |
Forecast period | 2022-2026 |
Growth momentum & CAGR | Accelerate at a CAGR of 7.94% |
Market growth 2022-2026 | USD 7.22 billion |
Market structure | Fragmented |
YoY growth (%) | 7.43 |
Regional analysis | Asia, North America, Europe, and Rest of World (ROW) |
Performing market contribution | Asia at 38% |
Key consumer countries | US, UK, China, Japan, and the Republic of Korea |
Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
Companies profiled | AbbVie Inc., Alcon Inc., Bausch Health Co. Inc., BVI Medical Inc., Carl Zeiss AG, Essilor International SAS, Haag Streit Group, Johnson and Johnson, NIDEK Co. Ltd, Ophtec BV, Orasis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanjeevan School For Perfect Eyesight, Sydnexis Inc., The Cooper Companies Inc., Topcon Corp., and Ziemer Ophthalmic Systems AG |
Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Myopia treatment - Market size and forecast 2021-2026
- Exhibit 28: Chart on Myopia treatment - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Myopia treatment - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Myopia treatment - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Myopia treatment - Year-over-year growth 2021-2026 (%)
- 5.4 Presbyopia treatment - Market size and forecast 2021-2026
- Exhibit 32: Chart on Presbyopia treatment - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Presbyopia treatment - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Presbyopia treatment - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Presbyopia treatment - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Type
- Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 Asia - Market size and forecast 2021-2026
- Exhibit 42: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.4 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.5 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 China - Market size and forecast 2021-2026
- Exhibit 58: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.8 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.9 Japan - Market size and forecast 2021-2026
- Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.10 Republic of Korea - Market size and forecast 2021-2026
- Exhibit 70: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
- 7.11 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Alcon Inc.
- Exhibit 85: Alcon Inc. - Overview
- Exhibit 86: Alcon Inc. - Business segments
- Exhibit 87: Alcon Inc. - Key offerings
- Exhibit 88: Alcon Inc. - Segment focus
- 10.4 Bausch Health Co. Inc.
- Exhibit 89: Bausch Health Co. Inc. - Overview
- Exhibit 90: Bausch Health Co. Inc. - Business segments
- Exhibit 91: Bausch Health Co. Inc. - Key news
- Exhibit 92: Bausch Health Co. Inc. - Key offerings
- Exhibit 93: Bausch Health Co. Inc. - Segment focus
- 10.5 Carl Zeiss AG
- Exhibit 94: Carl Zeiss AG - Overview
- Exhibit 95: Carl Zeiss AG - Business segments
- Exhibit 96: Carl Zeiss AG - Key offerings
- Exhibit 97: Carl Zeiss AG - Segment focus
- 10.6 Essilor International SAS
- Exhibit 98: Essilor International SAS - Overview
- Exhibit 99: Essilor International SAS - Product / Service
- Exhibit 100: Essilor International SAS - Key offerings
- 10.7 Haag Streit Group
- Exhibit 101: Haag Streit Group - Overview
- Exhibit 102: Haag Streit Group - Product / Service
- Exhibit 103: Haag Streit Group - Key offerings
- 10.8 Johnson and Johnson
- Exhibit 104: Johnson and Johnson - Overview
- Exhibit 105: Johnson and Johnson - Business segments
- Exhibit 106: Johnson and Johnson - Key news
- Exhibit 107: Johnson and Johnson - Key offerings
- Exhibit 108: Johnson and Johnson - Segment focus
- 10.9 NIDEK Co. Ltd
- Exhibit 109: NIDEK Co. Ltd - Overview
- Exhibit 110: NIDEK Co. Ltd - Business segments
- Exhibit 111: NIDEK Co. Ltd - Key news
- Exhibit 112: NIDEK Co. Ltd - Key offerings
- Exhibit 113: NIDEK Co. Ltd - Segment focus
- 10.10 Ophtec BV
- Exhibit 114: Ophtec BV - Overview
- Exhibit 115: Ophtec BV - Product / Service
- Exhibit 116: Ophtec BV - Key offerings
- 10.11 Topcon Corp.
- Exhibit 117: Topcon Corp. - Overview
- Exhibit 118: Topcon Corp. - Business segments
- Exhibit 119: Topcon Corp. - Key news
- Exhibit 120: Topcon Corp. - Key offerings
- Exhibit 121: Topcon Corp. - Segment focus
- 10.12 Ziemer Ophthalmic Systems AG
- Exhibit 122: Ziemer Ophthalmic Systems AG - Overview
- Exhibit 123: Ziemer Ophthalmic Systems AG - Product / Service
- Exhibit 124: Ziemer Ophthalmic Systems AG - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 125: Inclusions checklist
- Exhibit 126: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 127: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 128: Research methodology
- Exhibit 129: Validation techniques employed for market sizing
- Exhibit 130: Information sources
- 11.5 List of abbreviations
- Exhibit 131: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website:
SOURCE Technavio